Zhong Yi-Lin, Wang Peng-Qian, Hao Dan-Li, Sui Feng, Zhang Feng-Bin, Li Bing
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Department of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
World J Gastrointest Oncol. 2023 Jan 15;15(1):36-54. doi: 10.4251/wjgo.v15.i1.36.
Gastric cancer (GC) is a common gastrointestinal tumor. Gastric precancerous lesions (GPL) are the last pathological stage before normal gastric mucosa transforms into GC. However, preventing the transformation from GPL to GC remains a challenge. Traditional Chinese medicine (TCM) has been used to treat gastric disease for millennia. A series of TCM formulas and active compounds have shown therapeutic effects in both GC and GPL. This article reviews recent progress on the herbal drugs and pharmacological mechanisms of TCM in preventing the transformation from GPL to GC, especially focusing on anti-inflammatory, anti-angiogenesis, proliferation, and apoptosis. This review may provide a meaningful reference for the prevention of the transformation from GPL to GC using TCM.
胃癌(GC)是一种常见的胃肠道肿瘤。胃癌前病变(GPL)是正常胃黏膜转变为GC之前的最后病理阶段。然而,预防GPL向GC的转变仍然是一项挑战。中医(TCM)用于治疗胃病已有数千年历史。一系列中药方剂和活性化合物在GC和GPL的治疗中均显示出疗效。本文综述了中药在预防GPL向GC转变方面的草药及药理机制的最新进展,尤其侧重于抗炎、抗血管生成、增殖和凋亡方面。本综述可能为运用中医预防GPL向GC的转变提供有意义的参考。